statistiche ricercatore

Continente	#
EU - Europa	1.016
NA - Nord America	654
AS - Asia	262
SA - Sud America	50
AF - Africa	7
Continente sconosciuto - Info sul continente non disponibili	2
OC - Oceania	2
Totale	1.993

Nazione	#
US - Stati Uniti d'America	639
PL - Polonia	497
IT - Italia	186
DE - Germania	121
SG - Singapore	78
CN - Cina	70
SE - Svezia	61
BR - Brasile	45
HK - Hong Kong	41
NL - Olanda	28
RU - Federazione Russa	25
IE - Irlanda	15
VN - Vietnam	15
BG - Bulgaria	14
CA - Canada	14
TR - Turchia	12
UA - Ucraina	10
FI - Finlandia	9
FR - Francia	9
BE - Belgio	8
IN - India	8
KR - Corea	8
CH - Svizzera	7
JP - Giappone	7
AT - Austria	6
IR - Iran	6
GB - Regno Unito	5
ID - Indonesia	3
LT - Lituania	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
AR - Argentina	2
BD - Bangladesh	2
CZ - Repubblica Ceca	2
DK - Danimarca	2
EG - Egitto	2
RO - Romania	2
SN - Senegal	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AU - Australia	1
BA - Bosnia-Erzegovina	1
BO - Bolivia	1
CL - Cile	1
EC - Ecuador	1
EU - Europa	1
GE - Georgia	1
GR - Grecia	1
HR - Croazia	1
IQ - Iraq	1
KE - Kenya	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LK - Sri Lanka	1
MA - Marocco	1
MX - Messico	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PH - Filippine	1
PT - Portogallo	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	1.993

Nome	#
Silencing efficacy prediction: a retrospective study on target mRNA features	338
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma	324
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma	298
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma	272
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma	201
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma	138
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients	133
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients	128
Circulatory mirna as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma	85
MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View	76
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma	32
Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia	27
Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation	21
Totale	2.073

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	60	0	0	0	0	0	0	0	0	0	19	23	18
2020/2021	289	24	23	32	31	32	30	25	13	16	32	9	22
2021/2022	184	8	7	25	13	11	17	8	7	19	11	12	46
2022/2023	320	16	34	14	40	9	49	49	44	36	8	13	8
2023/2024	200	13	4	7	9	36	17	47	22	8	6	20	11
2024/2025	375	9	14	32	52	36	28	52	30	55	67	0	0
Totale													2.073

ArTS Archivio della ricerca di Trieste